A bioluminescent indicator glows when a cancer drug is active inside the brain, identifying which medications cross the blood-brain barrier.
Category: Drug Development
Making the invisible visible to improve heart surgery outcomes
Scientists find a way in mice to illuminate the cardiac conduction system during surgery to prevent unintended damage to healthy tissue.
Basic biochemistry research leads to heart-saving drug
Researchers at Stanford Medicine discovered the mechanism for a heart condition and developed a drug to treat it.
Machine learning could enable faster, less costly epilepsy drugs
Researchers created an algorithm to determine if mice have epilepsy and whether they have been treated with seizure drugs.
Cancer-detecting wearable may offer better way to monitor tumors
Researchers from Stanford have developed a wearable sensor to monitor the size of tumors, which could assist new cancer drug evaluations.
Molecular movie maker
Researchers are harnessing an imaging technique called cryogenic electron microscopy to design drugs and better understand disease.
Stanford Medicine magazine explores the molecules within us
Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
Preparing for the viruses we’ve yet to meet
Researchers at Stanford Medicine are working to develop antivirals to stop the current pandemic and prevent ones.
Precision medicine predicts best ulcerative colitis care for teens
Stanford researchers are developing a faster way to match each ulcerative colitis patient with the treatment that will work best for them.
Bringing principles of ethics to AI and drug design
Researchers discuss the need for ethics and its integration into research projects that harness artificial intelligence.
New drug gives patient his sight back
A Stanford patient improved greatly after being the first person with sight-threatening thyroid eye disease to receive the drug teprotumumab.
Small molecule lends big hope for brutal seizure disorder
Stanford researchers are investigating the use of a small molecule to treat Dravet syndrome, a devastating childhood neurologic disorder.
Can Prozac fight brain cancer?
The common antidepressant Prozac melts away glioblastoma tumors in laboratory mice, suggesting possible treatment for the deadly cancer.
Engineered tissue sent into space to test muscle loss drugs
To help us understand muscle loss as we age, a Stanford Medicine research team’s engineered tissue is sent to the International Space Station.
Keeping treatment-resistant skin cancer cells in check
Anthony Oro is devoted to understanding the origin of basal cell carcinomas. Now he's found how some become resistant to a common treatment.
Computer simulation may yield new COVID-19 drug
Stanford Medicine researchers have discovered a drug that could potentially be used to stave off SARS-CoV-2, the virus that causes COVID-19.